Burundi

in page functions
[French]
Total population (2016) 11,552,538
Birth cohort (2016) 498,332
Surviving Infants (surviving to 1 year per year, 2016) 462,056
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 54/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 82/1000
World Bank Index, IDA (2012) 3.08
Co-financing status (2016) Initial self-financing
No. of districts/territories (2014) 45

Gavi support for Burundi

Type of support

Approvals

2001-2020 (US$)
(30 Apr 2016)

Commitments

2001-2020 (US$)
(30 Apr 2016)

Disbursements

2000-2016 (US$)
(30 Apr 2016)

% Disbursed

(30 Apr 2016)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Cash Support (CASHSUPP) $152,500 $177,500
Civil Society Organisation support (CSO) $461,520 $461,520 $494,529 107%
Health system strengthening (HSS 1) $8,252,000 $8,252,000 $8,252,000 100%
Health system strengthening (HSS 2) $15,522,663 $15,522,663 $12,265,394 79%
HepB mono (NVS) $460,000 $460,000 $460,000 100%
HPV Demo (NVS) $239,043 $239,043 $126,458 53%
Immunisation services support (ISS) $3,669,980 $3,669,980 $3,669,980 100%
Injection safety support (INS) $390,294 $390,294 $390,294 100%
IPV (NVS) $1,415,500 $2,337,500 $779,873 55%
Measles (NVS) $411,003 $411,003 $431,185 105%
Penta (NVS) $34,133,969 $34,133,969 $32,967,122 97%
Pneumo (NVS) $33,778,688 $33,778,688 $39,303,575 116%
Rotavirus (NVS) $5,272,165 $5,272,165 $5,300,232 101%
Tetra DTP-Hib (NVS) $4,727,594 $4,727,594 $4,727,594 100%
Vaccine Introduction Grant (VIG) $1,264,000 $1,264,000 $1,264,000 100%
Total $110,150,919 $111,097,919 $110,432,236

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Burundi DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 95%
M:F sex ratio at birth (2016) 1.03
Household survey: DTP3 coverage for male (2009) 95.50%
Household survey: DTP3 coverage for female (2009) 95.20%
Household survey: Last DTP3 survey (2009) 95%
% districts achieving > 80% DTP3 coverage (2014) 84%
% districts achieving < 50% DTP3 coverage (2014) 0%
MCV WHO/UNICEF estimates (2014) 94%

Breakdown of support

Non-vaccine support Vaccine support
24% 76%
$26,336,196 $84,096,037

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Burundi

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

22 April 2014

World Immunisation Week 2014

Message by Dr Seth Berkley for the World Immunisation Week

04 February 2014

HPV vaccine with GAVI support

206,000 more girls to benefit from HPV vaccine with GAVI Alliance support

10 countries approved in latest round of HPV vaccine demonstration programmes.

close icon

modal window here